2019 NL Pharmacy Board Elections – Call for Nominations in Zones 2 and 3

It’s election time again! The Call for Nominations for Zones 2 and 3 was circulated on February 1, 2019 to all pharmacists practicing in those zones. The deadline to submit nominations is March 3, 2019. Please check your inboxes for the Call for Nominations email and form.

Please consider putting your name to serve the profession in its mandate of self-regulation!

NL Pharmacy Board Awards – Call for Nominations

Nominations are now open for the NLPB Certificate of Recognition and Patient Safety Award. Details on the awards and a copy of the nomination form can be found at http://nlpb.ca/media/NLPB-Awards-and-Honours-Jan2017.pdf. The deadline to submit nominations is March 15, 2019.

These awards, along with the Emerald Achievement Award which recognizes NLPB registrants who have practiced pharmacy for at least 35 years, will be presented at a reception held by the NL Pharmacy Board on May 3, 2019.

Please consider nominating a fellow pharmacist or pharmacy technician today!

The Pharmacist’s Role in the Provision of Mifegymiso

Recently, the NLPB office has received several questions related to the prescribing and dispensing of Mifegymiso (mifepristone tablet/misoprostol tablets) as indicated for medical termination of a developing intra-uterine pregnancy. Therefore, we thought it would be helpful to registrants if we shared the answers to frequently-asked-questions more broadly.

Can a pharmacist dispense Mifegymiso?
Yes, as of November 2017, Mifegymiso can be dispensed directly to patients by a pharmacist or a prescribing health professional.

Does a pharmacist have to be authorized by NLPB in order to dispense Mifegymiso?
No, NLPB does not have a specific standard of practice or an authorization process for pharmacists to dispense Mifegymiso. However, as always, pharmacists must self-govern and practice only within the boundaries of their knowledge, skills, and professional competence.

Can a pharmacist prescribe Mifegymiso?
No, prescribing of Mifegymiso does not fall within the scope of prescribing by pharmacists. Mifegymiso is a schedule I product. It is not considered “emergency contraception” as it is used for termination of a developing pregnancy; therefore, the authority to prescribe Mifegymiso is not captured under the category of minor ailment prescribing. There are specific requirements for the prescribing of Mifegymiso listed in the product monograph and on the Health Canada website. It should be prescribed by health professionals with prior adequate knowledge of medical abortion and use of Mifegymiso, or who have completed a Mifegymiso education program.

How can I learn more about Mifegymiso?
As per the statement issued by Health Canada, the most recent product monograph for Mifegymiso, an education program, and educational and information tools are available to all health professionals on the Celopharma website. The product monograph can also be accessed on the Health Canada website. Pharmacists should review the complete product monograph for prescribing information including indication, contraindications, serious warnings and precautions, and adverse events.

Medicinal Cannabis – No Deliveries to Pharmacies

The Board has been receiving questions regarding the deliveries of medicinal cannabis from a licensed cannabis seller on behalf of a patient.
As stated in the federal Cannabis Regulations, medicinal cannabis cannot be shipped to a patient’s pharmacy. The shipping address can be the client’s residence, mailing address if it differs from the patient’s residence, or the office of the health care practitioner who provided the medical document, and has consented to receive cannabis products on the patient’s behalf. It is important to note that pharmacists are not included in the definition of a healthcare practitioner in the Cannabis Regulations.

For more information please see Section 279(1)(e) of The Cannabis Regulations.

The Prescribing Course – Safe Opioid Prescribing

The Atlantic Mentorship Network-Pain & Addiction will be hosting The Prescribing Course – Safe Opioid Prescribing on Saturday, February 23, 2019 at the Josiah Squibb Memorial Pavilion at the Carbonear Long-Term Care Centre.

For more information and to register, visit: https://www.eventbrite.ca/e/the-prescribing-course-safe-opioid-prescribing-tickets-53807266984.

Calling All Pharmacy Technicians & Assistants!

The Canadian Association of Pharmacy Technicians is holding its 2019 Annual Conference May 3-5, 2019 in St. Andrews, New Brunswick at the beautiful Algonquin Resort.

The conference will provide attendees with the opportunity to learn new techniques and to see where the profession is heading at a provincial and national level. Each year this event continues to grow with more technicians getting involved in this profession and its future in Canada.

For information on the conference program and to register, visit https://capt.ca/event/pdc/. Register by
March 1, 2019 to qualify for the Early Bird Discount.

Regular Reminders

Registrant Contact Information – Registrants are responsible for ensuring that the contact information on their registrant profile, including email address and practice site, is accurate at all times. The NLPB primarily uses email communication to send newsletters, renewal reminders, practice site assessment information, professional development audit information, calls for interest for committees, and other alerts. If the email address on file is incorrect, important information may be missed and/or disclosed to the wrong person. If your contact information changes, please log into the NLPB Online Registrant Portal to update your file with your new contact information as soon as possible.

Proof of Continuous Professional Liability Insurance Coverage – In accordance with provincial legislation and the NLPB Policy – Professional Liability Insurance Requirements for Registration, all NLPB registrants are required to provide proof of continuous professional liability insurance coverage. Each year, when you renew your policy, once a copy of the new certificate/policy is received, you must upload an electronic copy of this documentation to your registrant profile. If you are uncertain how to do so, please click on this link for instructions: How to Upload Documents.

Forgot Your Password? – You can retrieve your NLPB Online Registrant Portal password at any time. Under the Login box, click the message that says, “Forgot your password? Click here to restore it.” On the next screen, enter your NLPB username, if you know it, or your email address. Click “Retrieve”. In a few minutes, you will receive an email with your username and password. Once you are logged in to your profile, you can change your password, if desired.

Receipts & Invoices – Did you know that NLPB’s Registrant Portal maintains all receipts created by the system. If, for any reason, you need a receipt or to view an invoice, you can do so at any time from your registrant profile. Once logged in, click on “Renewal Other/Invoices” and then select either “view invoice” or “print invoice” next to the one you are interested in.

This e-newsletter contains information on a wide variety of topics intended to enhance the practice of pharmacy in the province of Newfoundland and Labrador. As it is published and circulated to all registrants on a monthly basis, it is the expectation of the NLPB that all registrants are aware of the matters contained therein.

©2020 Newfoundland & Labrador Pharmacy Board